Expression and role of NGX6 in tumor

doi:10.3760/cma.j.issn.1673422X.2015.08.012

Abstract

Abstract: NGX6 is a recently discovered tumorsuppressor gene, which can inhibit tumor invasion and metastasis via suppressing tumor angiogenesis and lymphangiogenesis. The expression of NGX6 gene has negative correlation with many tumors, such as nasopharyngeal carcinoma, lung cancer, colon cancer and so on. Therefore, the measurement of NGX6′s level has a great influence on the prognosis of patients with tumor.

Key words: Neoplasms, Neoplasm metastasis, Nasopharyngeal carcinomaassociated gene 6

LIU Jin-Feng, JIANG Hao. Expression and role of NGX6 in tumor[J]. Journal of International Oncology, 2015, 42(8): 605-607.

References

［1］ Wang L, Xiang B, Yi M, et al. Identification of a new sevenspan transmembrane protein: NGX6a is downregulated in nasopharyngeal carcinoma and is associated with tumor metastasis［J］. J Histochem Cytochem, 2010, 58(1): 4151. ［2］ Lin ZF, Shen XY, Lu FZ, et al. Reveals new lung adenocarcinoma cancer genes based on gene expressions［J］. Eur Rev Med Pharmacol Sci, 2012, 16(9): 12491256. ［3］ Liu M, Wang X, Peng Y, et al. Egr1 regulates the transcription of NGX6 gene through a Sp1/Egr1 overlapping site in the promoter［J］. BMC Mol Biol, 2014, 15: 14. ［4］谭俞佳, 江青山. 肿瘤转移相关分子与鼻咽癌转移关系的研究进展［J］. 中南医学科学杂志, 2014, 46(2): 622625. ［5］ Guo Q, Wu M, Lian P, et al. Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells though modulation of the Wnt/betacatenin signaling pathway［J］. Mol Cell Biochem, 2009, 330(12): 7181. ［6］苏胜发, 卢冰, 苏敏, 等. iASPP蛋白在非小细胞肺癌中的表达及其意义［J］. 肿瘤预防与治疗, 2009, 22(4): 371376. ［7］ Zhu S, Pan W, Shi P, et al. Modulation of experimental autoimmune encephalomyelitis through TRAF3mediated suppression of interleukin 17 receptor signaling［J］. J Exp Med, 2010, 207(12): 26472662. ［8］ Hu Y, Ota N, Peng I, et al. IL17RC is required for IL17Aand IL17Fdependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis［J］. J Immunol, 2010, 184(8): 43074316. ［9］ Iwakura Y, Ishigame H, Saijo S, et al. Functional specialization of interleukin17 family members［J］. Immunity, 2011, 34(2): 149162. ［10］吴静娴. NGX6蛋白在鼻咽癌中的表达及其与VEGF表达和LMVD的相关性研究［D］. 上海: 第二军医大学, 2009. ［11］崔荣记. NGX6, IL17F在大肠癌中的表达意义与VEGF相关性研究［D］. 南充: 川北医学院, 2014. ［12］ Guo Q, Shen S, Liao M, et al. NGX6 inhibits cell invasion and adhesion through suppression of Wnt/betacatenin signal pathway in colon cancer［J］. Acta Biochim Biophys Sin (Shanghai), 2010, 42(7): 450456. ［13］ Liu M, Peng Y, Wang X, et al. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer［J］. BMC Cancer, 2010, 10: 160. ［14］ Merlo V, Longo M, Novello S, et al. EGFR pathway in advanced nonsmall cell lung cancer［J］. Front Biosci (Schol Ed), 2011, 3: 501517. ［15］ Zhu J, Chen M, Chen N, et al. Glycyrrhetinic acid induces G1phase cell cycle arrest in human nonsmall cell lung cancer cells through endoplasmic reticulum stress pathway［J］. Int J Oncol, 2015, 46(3): 981988. ［16］王国磊, 蒋庆峰, 张瑞祥, 等. NGX6和CyclinD1蛋白在食管鳞癌组织中的表达及意义［J］. 中国癌症杂志, 2010, 20(12): 887891. ［17］章辉, 曹学全, 范广民, 等. 胃癌组织NGX6和CyclinD1表达及其生物学意义的探讨［J］. 中华肿瘤防治杂志, 2012, 19(8): 612614. ［18］代志鹏. NGX6、VEGF基因在胃癌组织中的表达及其临床意义［J］. 新乡医学院学报, 2012, 29(11): 881883. ［19］ Liu J, Zhu X, Xu X, et al. DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells［J］. Med Oncol， 2014， 31(1): 817. ［20］杨波, 张速勤, 李兆基. 抑癌基因NGX6研究进展［J］. 医学研究生学报, 2010, 23(3): 334336. ［21］ Xiao JD, Shen SR. Expression and significance of NGX6 gene in human hepatocellular carcinoma［J］. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2008, 33(10): 937941. ［22］ Takagi S, Banno H, Hayashi A, et al. HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK285［J］. Oncoscience, 2014, 1(3): 196204. ［23］ EskandariNasab E, Hashemi M, Rezaei H, et al. Evaluation of UDPglucuronosyltransferase 2B17 (UGT2B17) and dihydrofolatereductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer［J］. Mol Biol Rep, 2012, 39(12): 1053110539.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.